slides · global inventory
Disclaimer
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,127
Current window 35,011-35,040
Pages 1,371
Rows per page 30
Component
35,011-35,040 of 41,127
07
The chart illustrates a shift in revenue seasonality from Q1/Q2 towards Q4 for the 2016 fiscal year.Inovalon | Results Presentation Deck | 22 slides · Inovalon
Conference presentation Investor relations Beat · Need1 hit
02
LionTree | Investment Banking Pitch Book | 25 slidesLionTree | Investment Banking Pitch Book | 25 slides · LionTree
Consulting deck Investment bank Beat · Situation & Context1 hit
06
Includes footnotes detailing pricing assumptions, share counts, and leverage calculations.LionTree | Investment Banking Pitch Book | 25 slides · LionTree
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Golden Circle1 hit
07
Includes a footnote regarding production loans.LionTree | Investment Banking Pitch Book | 25 slides · LionTree
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Golden Circle1 hit
12
Includes footnotes regarding methodology for equity value and EBITDA multiples.LionTree | Investment Banking Pitch Book | 25 slides · LionTree
Consulting deck Investment bank Beat · Evidence & ProofLoop · Golden Circle1 hit
15
Includes valuation bridge, EBITDA multiples, leverage ratios, and a multi-line stock performance chart.LionTree | Investment Banking Pitch Book | 25 slides · LionTree
Consulting deck Investment bank Beat · Evidence & ProofLoop · Golden Circle1 hit
17
Assumes mid-year convention, discounted back to 3/31/16; based on balance sheet as of 3/31/16 (net debt of $788mm), equity in affiliates of $808mm and minority interest of $98mm; excludes value of operating losses which have been incorporated in the 15.0% tax rate.LionTree | Investment Banking Pitch Book | 25 slides · LionTree
Consulting deck Investment bank Beat · Evidence & ProofLoop · Golden Circle1 hit
21
Includes a detailed buildup of the Combined Pro Forma Equity Value and the resulting accretion percentage.LionTree | Investment Banking Pitch Book | 25 slides · LionTree
Consulting deck Investment bank Beat · Impact & Next Steps1 hit
23
The chart uses color coding to distinguish between Buy, Hold, and Sell ratings.LionTree | Investment Banking Pitch Book | 25 slides · LionTree
Consulting deck Investment bank Beat · Impact & Next Steps1 hit
24
The chart uses a horizontal bar format to visualize the gap between the current price ($20.55) and the average target ($28.75).LionTree | Investment Banking Pitch Book | 25 slides · LionTree
Consulting deck Investment bank Beat · Impact & Next Steps1 hit
41
Includes a 'Draft Working Materials' header.LionTree | Investment Banking Pitch Book | 41 slides · LionTree
Consulting deck Investment bank 1 hit
02
Shopify | Start Up Pitch Deck | 29 slidesShopify | Start Up Pitch Deck | 29 slides · Shopify
Pitch deck Investor relations Beat · Humble Origins1 hit
10
Uses a Venn-style diagram to show subset relationship between current core geographies and global TAM.Shopify | Start Up Pitch Deck | 29 slides · Shopify
Pitch deck Investor relations Beat · Rising Success1 hit
20
The slide includes a legend for revenue segments and a list of growth drivers.Shopify | Start Up Pitch Deck | 29 slides · Shopify
Pitch deck Investor relations Beat · The Breakthrough1 hit
21
The slide includes a formal definition of MRR in the footer.Shopify | Start Up Pitch Deck | 29 slides · Shopify
Pitch deck Investor relations Beat · The Breakthrough1 hit
24
The chart illustrates operating leverage by showing the decline in total operating expenses as a percentage of revenue over time.Shopify | Start Up Pitch Deck | 29 slides · Shopify
Pitch deck Investor relations Beat · Ultimate Achievement1 hit
02
Standard regulatory disclaimer for medical device presentations.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Setup1 hit
03
Includes a mandatory FDA disclaimer at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Setup1 hit
04
Includes a standard FDA disclaimer at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Setup1 hit
05
Includes FDA disclaimer at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Setup1 hit
06
Includes FDA disclaimer at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Setup1 hit
07
Includes FDA disclaimer at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Setup1 hit
08
Includes FDA disclaimer at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Setup1 hit
09
Includes a disclaimer at the bottom regarding FDA status.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Setup1 hit
10
Includes a standard Theranos FDA disclaimer at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Setup1 hit
11
The slide showcases hardware components for clinical chemistry, immunochemistry, hematology/immunology, and molecular biology.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
12
The slide displays six distinct hardware components: Camera, Material Handling Robot, Cartridge, Sonicator, Thermocycler, and Centrifuge.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
13
The slide includes a disclaimer about FDA clearance status.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
14
The slide includes a disclaimer about FDA approval status.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
15
Includes a disclaimer regarding FDA clearance status.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit